Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports
(100 Reports)
ACE Reports
Originals
(2 Articles)
Originals
Podcasts
(0 Videos)
Podcasts
Our AI driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Metabolic Disorders
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
Lancet Oncol. 2014 Apr;15(4):474-82. doi: 10.1016/S1470-2045(14)70035-X. Epub 2014 Mar 11
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
This report has been verified by one or more authors of the original publication.
Lancet Oncol. 2014 Apr;15(4):474-82. doi: 10.1016/S1470-2045(14)70035-X. Epub 2014 Mar 11
Metabolic Disorders
Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study
Osteoporos Int. 2019 Mar;30(3):637-645. doi: 10.1007/s00198-018-4773-5
Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study
Osteoporos Int. 2019 Mar;30(3):637-645. doi: 10.1007/s00198-018-4773-5
Metabolic Disorders
Fracture Prevention with Zoledronate in Older Women with Osteopenia
N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Fracture Prevention with Zoledronate in Older Women with Osteopenia
This report has been verified by one or more authors of the original publication.
N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082
Arthroplasty
Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis
J Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7
Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis
J Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7
Metabolic Disorders
Comparative adherence to weekly oral and quarterly intravenous bisphosphonates among patients with limited heath literacy who sustained distal radius fractures
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Comparative adherence to weekly oral and quarterly intravenous bisphosphonates among patients with limited heath literacy who sustained distal radius fractures
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Metabolic Disorders
Effect of balance training on falls in patients with osteoporosis: A systematic review and meta-analysis
J Rehabil Med. 2018 Jul 17;50(7):577-581. doi: 10.2340/16501977-2334
Effect of balance training on falls in patients with osteoporosis: A systematic review and meta-analysis
J Rehabil Med. 2018 Jul 17;50(7):577-581. doi: 10.2340/16501977-2334
Metabolic Disorders
Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials
Climacteric. 2018 Apr;21(2):189-195
Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials
Climacteric. 2018 Apr;21(2):189-195
Metabolic Disorders
Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and metaanalysis
Expert Opin Drug Saf. 2018 Apr;17(4):413-428
Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and metaanalysis
Expert Opin Drug Saf. 2018 Apr;17(4):413-428
Metabolic Disorders
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
Osteoporos Int. 2016 Nov;27(11):3289-3300
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
This report has been verified by one or more authors of the original publication.
Osteoporos Int. 2016 Nov;27(11):3289-3300
Metabolic Disorders
Abaloparatide Reduced the Risk of Major Nonvertebral Fractures in Postmenopausal Women with Osteoporosis
Abaloparatide Reduced the Risk of Major Nonvertebral Fractures in Postmenopausal Women with Osteoporosis
General Orthopaedics
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
Metabolic Disorders
Eldecalcitol improves muscle strength and dynamic balance in postmenopausal women with osteoporosis: an open-label randomized controlled study
J Bone Miner Metab. 2016 Sep;34(5):547-54
Eldecalcitol improves muscle strength and dynamic balance in postmenopausal women with osteoporosis: an open-label randomized controlled study
J Bone Miner Metab. 2016 Sep;34(5):547-54
Metabolic Disorders
Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass
BMC Musculoskelet Disord. 2016 Jun 8;17(1):254
Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass
BMC Musculoskelet Disord. 2016 Jun 8;17(1):254
Metabolic Disorders
Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion
Osteoporos Int. 2016 Apr;27(4):1469-76
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion
Osteoporos Int. 2016 Apr;27(4):1469-76
Metabolic Disorders
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
J Clin Endocrinol Metab. 2016 May;101(5):2023-30
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
J Clin Endocrinol Metab. 2016 May;101(5):2023-30
Metabolic Disorders
Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
Osteoporos Int. 2016 Jun;27(6):1989-98
Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
Osteoporos Int. 2016 Jun;27(6):1989-98
Metabolic Disorders
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
This report has been verified by one or more authors of the original publication.
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Metabolic Disorders
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial
J Clin Densitom. 2016 Jul-Sep;19(3):346-51
Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial
This report has been verified by one or more authors of the original publication.
J Clin Densitom. 2016 Jul-Sep;19(3):346-51
Metabolic Disorders
Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials
J Diabetes. 2014 May;6(3):260-6. doi: 10.1111/1753-0407.12102. Epub 2013 Nov 22
Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials
J Diabetes. 2014 May;6(3):260-6. doi: 10.1111/1753-0407.12102. Epub 2013 Nov 22
Metabolic Disorders
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bis
Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28.
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bis
Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28.
Showing 1-20 of 100 results
1
2
3
4
5